Increase the pressor effect of phenylephrine hydrochloride.
Source: NLP:phenylephrine hci
15 interactions on record
Increase the pressor effect of phenylephrine hydrochloride.
Source: NLP:phenylephrine hci
Increase the pressor effect of phenylephrine hydrochloride.
Source: NLP:phenylephrine hydrochloride
Concomitant use may enhance the pressor response and increase the risk of hypertension.
Source: NLP:promethazine, phenylephrine, codeine
May potentiate hypokalemia or ECG changes. Use with caution.
Source: NLP:arformoterol tartrate
May potentiate hypokalemic effect of formoterol. Use with caution.
Source: NLP:formoterol fumarate
May potentiate hypokalemic effect of formoterol. Use with caution.
Source: NLP:formoterol fumarate dihydrate
May increase glucose-lowering effect of glimepiride, increasing susceptibility to hypoglycemia.
Source: NLP:glimepiride
Lessen the skin test wheal and erythema responses elicited by histamine at the skin test site. Should be discontinued for at least 2-3 weeks before skin testing.
Source: NLP:histamine
May decrease serum thyroxine-binding globulin concentration, resulting in initial transient increase in FT4 followed by decreased serum T4.
Source: NLP:levothyroxine sodium
May decrease serum thyroxine-binding globulin concentration, altering T3 serum transport. Closely monitor thyroid hormone parameters.
Source: NLP:liothyronine sodium
Concomitant use may lead to hypokalemia development. Use with caution and monitor potassium levels.
Source: NLP:methazolamide
May elevate and prolong serum methotrexate levels and increase toxicity; can be continued or reduced gradually in responding patients.
Source: NLP:methotrexate
Somatropin may alter clearance of sex steroids metabolized by CYP450 liver enzymes; careful monitoring is advised.
Source: NLP:somatropin
Steroids may potentiate hypokalemia or ECG changes when used with olodaterol. Use with caution.
Source: NLP:tiotropium bromide and olodaterol
Ipratropium bromide HFA inhalation aerosol has been used concomitantly with oral steroids in COPD treatment; no formal studies fully evaluating interaction effects with respect to safety and effectiveness.
Source: NLP:ipratropium bromide inhalation